| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |